As the year begins under a new Trump Administration, healthcare providers and private equity firms should consider the antitrust enforcement environment they are likely to face in 2025. This Holland & Knight report recaps...more
1/27/2025
/ Antitrust Division ,
Antitrust Provisions ,
Competition ,
Department of Justice (DOJ) ,
Enforcement Actions ,
Federal Trade Commission (FTC) ,
Hart-Scott-Rodino Act ,
Mergers ,
Non-Compete Agreements ,
Private Equity ,
State and Local Government ,
Trump Administration
2024 has been an eventful year for federal and state antitrust enforcement in healthcare with many in the industry wondering where do we go from here in 2025. Holland & Knight sponsored a breakout panel discussion at the...more
10/14/2024
/ Acquisitions ,
Antitrust Provisions ,
Best Practices ,
Corporate Practice of Medicine ,
Department of Justice (DOJ) ,
Enforcement ,
Federal Trade Commission (FTC) ,
Governor Newsom ,
Hart-Scott-Rodino Act ,
Mergers ,
Pending Legislation ,
Portfolio Companies ,
Premerger Notifications ,
Private Equity ,
Proposed Legislation
Amendments made by the California Office of Health Care Affordability (OHCA) to its cost and market impact review (CMIR) regulations became effective on Aug. 22, 2024, and serve to expand the scope of the Health Care Quality...more
9/16/2024
/ Acquisitions ,
Amended Regulation ,
Change in Control ,
Corporate Practice of Dentistry ,
Corporate Practice of Medicine ,
Dental Practice ,
Hart-Scott-Rodino Act ,
Healthcare Facilities ,
Material Change Doctrine ,
Mergers ,
Pending Legislation ,
Private Equity ,
Private Equity Funds ,
Reporting Requirements ,
State Attorneys General
Private equity sponsors can exhale: A federal court recently stopped the Federal Trade Commission's (FTC) antitrust action that targeted private equity sponsor Welsh, Carson, Anderson & Stowe for the healthcare "roll-up"...more
6/4/2024
/ Acquisitions ,
Antitrust Provisions ,
Corporate Practice of Medicine ,
Federal Trade Commission (FTC) ,
FTC Act ,
Hart-Scott-Rodino Act ,
Health Care Providers ,
Injunctive Relief ,
Popular ,
Portfolio Companies ,
Private Equity ,
Section 5